Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Esketamine Versus Electroconvulsive Therapy for Suicidal Ideation in Depressive Episodes: a Multicenter Randomized Controlled Trial

NCT06355180 is registered in ClinicalTrials.gov with Capital Medical University as lead sponsor.

NCT NCT06355180
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06355180 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Esketamine Versus Electroconvulsive Therapy for Suicidal Ideation in Depressive Episodes: a Multicenter Randomized Controlled Trial
Lead sponsor
Capital Medical University
Phase
Not applicable
Overall status
Completed
Start date
April 16, 2024
Completion date
August 28, 2025
Enrollment
340 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

depressive episode, mood disorders, suicidal ideation